Monarch Partners Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.7M | Sell |
|
|||||
|
2022
Q3 | $2.05M | Hold |
|
|||||
|
2022
Q2 | $2.88M | Buy |
|
|||||
|
2022
Q1 | $3.06M | Hold |
|
|||||
|
2021
Q4 | $3.48M | Buy |
|
|||||
|
2021
Q3 | $2.3M | Sell |
|
|||||
|
2021
Q2 | $2.87M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $377K | Hold |
|
|||||
|
2019
Q3 | $380K | Buy |
|
|||||
|
2019
Q2 | $218K | Hold |
|
|||||
|
2019
Q1 | $469K | Buy |
|